Can Ayahuasca Trigger Psychosis? What the Evidence Shows

Yes, Ayahuasca can, in rare cases, trigger a prolonged psychotic episode or a manic switch, and the risk is meaningfully higher for people with a personal or family history of psychosis, schizophrenia, or bipolar disorder. That is precisely why reputable retreats and clinical trials screen these conditions out. For most people the experience is intense but self-limiting; the danger is real, uncommon, and largely concentrated in identifiable, vulnerable groups.

Can Ayahuasca cause psychosis?

The honest answer is: rarely, but yes, and the rarity matters as much as the risk. Ayahuasca contains DMT, a powerful serotonergic psychedelic, and like other classic psychedelics it can in unusual cases precipitate a psychotic episode that outlasts the ceremony itself. A systematic review of the human literature by dos Santos, Bouso and Hallak (2017) found only a handful of published case reports and case series describing psychotic episodes linked to Ayahuasca, and concluded that "the incidence of such episodes appears to be rare in both the ritual and the recreational/non-controlled settings." ^[1]

That is reassuring, but it is not "safe for everyone." The same review noted that most affected individuals had a personal or family psychiatric history, and that a minority of cases occurred in people without any obvious prior vulnerability. ^[1] Rare is not the same as zero, and the consequences when it does happen can be severe.

If you want the foundations first, our pillar on what Ayahuasca is explains the brew and its active compounds; this article focuses specifically on the psychiatric risk.

Who is most at risk: psychosis, schizophrenia and bipolar history

The clearest signal in the evidence is that risk is not evenly distributed. People with a personal or family history of psychotic illness are substantially more vulnerable. The 2017 review found that affected cases frequently involved a history of psychosis, schizophrenia, schizophreniform disorders, psychotic mania, or psychotic depression. ^[1] The non-profit research body ICEERS reaches the same conclusion and states plainly that individuals with a personal or family history of any psychotic illness or non-psychotic mania should avoid hallucinogen intake. ^[2]

Bipolar disorder deserves its own warning. Beyond psychosis, psychedelics can trigger a manic or hypomanic switch. A 2026 systematic review and meta-analysis in Molecular Psychiatry found rates of psychedelic-associated mania or hypomania ranging from about 5.8% in controlled psilocybin trials to roughly 30% in naturalistic studies of people who already had bipolar disorder, with higher risk among those with bipolar I, familial vulnerability, polysubstance use, and unsupervised use. ^[3] Encouragingly, when mania did occur it was "typically acute and self-limited," but a manic episode is still a serious psychiatric event. ^[3]

Why these are standard exclusion criteria

Every credible modern psychedelic trial excludes participants with a personal or family history of psychotic and bipolar disorders, and the better retreats mirror those exclusions. There is a strong evidence-based reason: the 2017 review concluded that psychiatric screening before administration "seems to significantly reduce the possibility of adverse reactions with psychotic symptomatology." ^[1] Notably, prolonged psychotic reactions are essentially absent from controlled experimental and clinical settings, where rigorous screening happens, and cluster instead in uncontrolled use. ^[2]

This is the single most useful safety lever a participant has, and it is one you can interrogate before you ever sit in ceremony. A centre that screens thoroughly is doing the protective work the science points to. Our guide to who should not take Ayahuasca and the pillar on Ayahuasca safety and contraindications cover the full exclusion list, and the questions to ask a retreat include exactly how to check whether their screening is real or a box-tick.

Psychiatric screening before administration seems to significantly reduce the possibility of adverse reactions with psychotic symptomatology.

What the surveys and case reports actually show

It helps to separate two kinds of evidence. Case reports document the rare severe outcomes, the prolonged psychotic episodes that prompt hospitalisation. They are individually alarming but few in number, and causation is often hard to prove because of pre-existing conditions or concurrent drug use. ^[1]

Large surveys capture the broader picture. The Global Ayahuasca Survey, the biggest study of its kind with thousands of respondents, found that adverse mental health effects were common, reported by 55.4% of participants on at least one occasion, but that the great majority were transient and were experienced as part of a difficult-but-meaningful process. Only 4.4% reported severe adverse mental health effects, and around 12% said they had needed professional support at some point. ^[4] A reanalysis of that dataset linked worse adverse outcomes to a prior history of anxiety and to use outside structured contexts. ^[5]

The takeaway: feeling shaken, anxious, or destabilised for a while after Ayahuasca is common and usually passes. A genuine, persistent psychotic break is not common, but it is the outcome the screening exists to prevent.

Transient distress versus a psychiatric emergency

This distinction is the most important thing in this article. The two can look superficially similar in the days after a ceremony, but they are not the same thing.

Transient post-ceremony distress is part of the normal range: emotional rawness, vivid dreams, low mood, anxiety, or feeling "cracked open." It typically eases over days to a couple of weeks and responds to rest, grounding, support and good integration. Our guide on preparing for a difficult experience covers how to ride this out.

A psychiatric emergency is different in kind. Warning signs that someone has crossed into a prolonged psychotic or manic state include:

• Persistent hallucinations or fixed false beliefs (delusions) that continue days after the substance has cleared, when sober. ^[6]
• Disorganised, incoherent thinking or speech, or a loss of contact with reality that does not resolve.
• Manic features: little or no need for sleep, racing thoughts, grandiosity, reckless behaviour.
• Inability to function, care for oneself, or stay safe.
• Any thoughts of suicide or of harming oneself or others.

These are not signs to "integrate." They are signs to get urgent medical help. Prolonged or worsening psychotic symptoms after psychedelic use warrant assessment by a clinician, ideally one who knows about psychedelics. ^[1]

How to lower the risk before you decide

You cannot reduce this risk to zero, but you can stack the odds sensibly. Be ruthlessly honest on any health questionnaire, concealing a psychiatric history removes the one safeguard the evidence most supports. Choose a centre with proper medical screening, qualified support, and a real plan for psychological emergencies, as set out in our pillar on choosing a retreat safely. And take medication interactions seriously: Ayahuasca's MAOI component reacts dangerously with several drug classes, covered in our piece on Ayahuasca and antidepressants.

Most of all, if psychosis, schizophrenia, or bipolar disorder runs in your family or your own history, the safest and most evidence-aligned course is not to participate, and to discuss the question with a psychiatrist who knows you. This article is educational and is not medical advice.